LFCR
LFCR
NASDAQ · Life Sciences Tools & Services

Lifecore Biomedical Inc

$3.80
-0.04 (-1.04%)
Financial Highlights (FY 2026)
Revenue
139.26M
Net Income
-41,840,666
Gross Margin
31.3%
Profit Margin
-30.0%
Rev Growth
-11.5%
D/E Ratio
2.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.3% 31.3% 44.5% 44.5%
Operating Margin -13.4% -12.0% 6.5% 6.6%
Profit Margin -30.0% -28.5% 5.3% 5.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 139.26M 157.32M 344.67M 265.26M
Gross Profit 43.55M 49.19M 153.43M 118.09M
Operating Income -18,632,912 -18,944,442 22.32M 17.47M
Net Income -41,840,666 -42,540,216 18.11M 14.22M
Gross Margin 31.3% 31.3% 44.5% 44.5%
Operating Margin -13.4% -12.0% 6.5% 6.6%
Profit Margin -30.0% -28.5% 5.3% 5.4%
Rev Growth -11.5% -11.5% +6.7% +0.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 52.01M 52.01M 31.30M 33.69M
Total Equity 18.91M 18.91M 172.81M 150.13M
D/E Ratio 2.75 2.75 0.18 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,523,266 -10,220,405 26.32M 22.29M
Free Cash Flow 8.29M 10.33M